 Lexicon Pharmaceuticals, Inc. NASDAQ:LXRX Research analysts at Wedbush boosted their Q3 2020 earnings per share estimates for shares of Lexicon Pharmaceuticals in a report issued on Monday, August 3rd. Wedbush analyst L. Moussatos now forecasts that the biopharmaceutical company will post earnings per share of 0.36 for the quarter, up from their previous forecast ... 